GlassScriptPhysician profile
David H Clements
NPI 1114995826
$34,518.47
in general payments reported to CMS, 2019-2025
12 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $17K · 2021: $585 · 2022: $447 · 2023: $197 · 2024: $111 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $16,594.69 | 2020-2025 | T2 Alpha |
| Medical Device Business Services, INC. | $14,544.37 | 2019-2021 | |
| Nuvasive, INC. | $2,391.22 | 2019 | |
| Biedermann Motech, INC. | $369.93 | 2022-2023 | Moss Vrs Spinal System |
| Neurocrine Biosciences, INC. | $146.50 | 2022-2025 | |
| Globus Medical, INC. | $111.07 | 2024 | Reline |
| Cerapedics INC. | $98.99 | 2022 | |
| Lundbeck LLC | $81.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.40 | 2022-2025 | Trintellix |
| Zimvie INC. | $50.81 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.50 | 2023-2025 | Caplyta |
| Nuvasive Specialized Orthopedics, INC. | $15.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.